N-domain angiotensin i-converting enzyme with 80 kda as a possible genetic marker of hypertension

Hypertension

Volumn 42, Issue 4, 2003, Pages 693-701

  Marques, Georgia D M ^a   Quinto, Beata M R ^a   Plavinik, Frida L ^a   Krieger, Josè E ^a   Marson, Odair ^a   Casarini, Dulce E ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme; Genetic; Genetics; Hypertension

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROLYTE BALANCE; ENVIRONMENTAL FACTOR; GENETIC MARKER; GENETIC MODEL; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; GENETIC MARKERS; HYPERTENSION; MALE; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, INBRED BN; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; SEQUENCE ALIGNMENT;

EID: 0141962694     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000085784.18572.CB     Document Type: Article

References (59)

1. Ribeiro AB, ed. Atualizaão em Hipertensão Arterial: Clínica, Diagnstico e Teraputica. São Paulo, Brazil: Atheneu; 1996: 1-7.
2. Soubrier F. Blood pressure gene at the angiotensin I-converting enzyme locus. Circulation. 1998; 97: 1763-1765.
3. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1990; 811-1000.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Willians SC, Charru A, Hunt SC, Hopkins PN, Willians RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992; 71: 169-180.
5. Caulfield M, Lavender P, Farral M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of angiotensinogen gene to essential hypertension. N Engl J Med. 1994; 330: 1629-1633.
6. Inoue I, Nakajima T, Willians CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription. J Clin Invest. 1997; 99: 1786-1797.
7. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzini C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of a-adducin and salt sensitivity in patients with essential hypertension. J Clin Invest. 1997; 349: 1353-1357.
8. Cusi D, Bianchi G. Genetics of essential (primary) hypertension: the contribution of renin studies in the rat and man. In: Robertson JIS, Nichols MG, eds. The Renin-Angiotensin System. London, UK: Gower Medical Publishing; 1993: 2.61.1-61.2.
9. Erdös EG, Skidgel RA. The angiotensin converting enzyme. Lab Invest. 1987; 56: 345-348.
10. Bianch G, Barlassina C. Renal function in essential hypertension. In: Genest J, Kuschel O, Hamet P, Cantin M, eds. Hypertension. New York, NY: McGraw-Hill; 1983: 54-73.
11. Yamori Y, Nara Y, Nabika T, Ikeda K, Matsumoto K. Prediction of hypertension and stroke for controlling cardiovascular diseases in genetic rat models. In: Berg V, Bullyzhenkorv Y, Christen P, eds. Genetic Approaches to Coronary Heart Disease and Hypertension. Berlin, Germany: SpringerVerlog; 1991: 81-97.
12. Soubrier F. Blood pressure gene at the angiotensin I-converting enzyme locus: chronicle of a gene foretold. Circulation. 1998; 97: 1763-1765.
13. Yamori Y, Horie R, Sato M, Handa H. Pathogenetic similarity of stroke-prone SHR and humans. Stroke. 1976; 7: 46-53.
14. Erdös EG, Yang HYT. An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci. 1967; 6: 569-574.
15. Cushman DW, Ondetti MA. Inhibitors of angiotensin-converting enzyme. In: Ellis GP, West GB, eds. Progress in Medical Chemistry. Amsterdam, The Netherlands: Elsevier/North-Holland Biomedical Press; 1980: 41-104.
16. Erdös EG. Angiotensin I converting enzyme and the changes in our concepts through the years (Lewis K. Dahl Memorial Lecture). Hypertension. 1990; 16: 363-370.
17. Wei L, Alhenc-Gelas F, Corvol P, Clauser F. The two homologous domains of the human angiotensin I-converting enzyme are both catalytically active. J Biol Chem. 1991; 266: 9002-9008.
18. Casarini DE, Alves KB, Costa RH, Plavnic FL, Morena MEM, Rodrigues CIS, Marson O. Effect of diuretics upon urinary levels of angiotensin converting enzyme (ACE) of essential mild hypertensive patients (EHP). Hypertension. 1991; 16: 463. Abstract.
19. Casarini DE, Carmona AK, Plavink FL, Zanella MT, Juliano L, Ribeiro AB. Calcium channel blockers as inhibitors of angiotensin I-converting enzyme. Hypertension. 1995; 26: 1145-1148.
20. Casarini DE, Plavink FL, Zanella MT, Marson O, Krieger JE, Hirata IY, Stella RCR. Angiotensin-converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol. 2001; 33: 75-85.
21. Marques GDM, Krieger JE, Casarini DE. Angiotensin I-converting enzyme: a possible genetic marker of hypertension. Presented at the 19th Scientific Meeting of the International Society of Hypertension; June 23-27, 2002; Prague, Czech Republic. J Hypertens. 2002;20:S263. Abstract.
22. Kohlmann O, Cesaretti ML, Ginosa M, Tavares A, Zanella MT, Ribeiro AB, Ramos OL, Leeman SE, Gavras I, Gavras H. Role of substance P in blood pressure regulation in salt-dependent experimental hypertension. Hypertension. 1997; 29: 506-509.
23. Haack D, Mohring JM, Mohring B, Petri M, Hackemthal E. Comparative study on the development of corticosterone and DOCA hypertension in rats. Am J Physiol. 1977; 233: F403-F411.
24. Friedland J, Silverstein E. A sensitive fluorometric assay for serum angiotensin converting enzyme. Am J Clin Pathol. 1976; 66: 416-424.
25. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dying. Anal Biochem. 1976; 72: 248-254.
26. Laemmli UK. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227: 680-685.
27. Leatherbarrow RJ. Grafit version 3.0. Stounes, UK: Erithacus Software Ltd; 1992.
28. Casarini DE, Alves KB, Arajo MS, Stella RCR. Endopeptidase and carboxypeptidase activities in human urine which hydrolyze bradykinin. Braz J Med Biol Res. 1992; 25: 219-229.
29. Bordier C. Phase separation of integral membrane proteins in Triton X-114. J Biol Chem. 1981; 256: 1604-1607.
30. Mattenhemeier H. Enzymology of kidney tissue. Curr Probl Clin Biochem. 1968; 2: 119-145.
31. Casarini DE, Boim MA, Stella RCR, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol. 1997; 272: F405-F409.
32. Casarini DE, Boim MA, Stella RCR, Schor N. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron. Am J Physiol. 1999; 277: F66-F74.
33. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974; 34: 1143-1153.
34. Dahl LK, Heine M, Tassinari L. Effects of chronic excess salt ingestion: evidence that genetic factors play an important role susceptibility to experimental hypertension. J Exp Med. 1962; 115: 1173-1190.
35. Schlager EL. Genetic hypertension in different strains of mice. In: De Jong W, ed. Handbook of Hypertension: Experimental and Genetic Models of Hypertension. Amsterdam, The Netherlands: Elsevier/North-Holland; 1984: 192-199.
36. Soubrier F, Hubert C, Testut P, Naudaud S, Alhenc-Gelas, Corvol P. Molecular biology of angiotensin converting enzyme, I: biochemistry and structure of the gene. J Hypertens. 1993; 11: 471-476.
37. Kasturi S, Jabbar MA, Sen GC, Sen I. Role of glycosylation in the biosynthesis and activity of rabbit testicular angiotensin-converting enzyme. Biochemistry. 1994; 33: 6228-6234.
38. Deddish P, Awang J, Michel B, Morris PW, Davidson NO, Skidgel RA, Erdös EG. Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci U S A. 1994; 91: 7804-7811.
39. Oppong SY, Hooper NM. Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. Biochem J. 1993; 292: 597-603.
40. Andrade MCC, Quinto BMR, Carmona AK, Ribas OS, Boim MA, Schor N, Casarini DE. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture. J Hypertens. 1998; 16: 2063-2074.
41. Piquilloud Y, Reinharz A, Roth M. Studies on the angiotensin-converting enzyme with different substrates. Biochem Biophys Acta. 1970; 206: 136-142.
42. Skeggs LT, Kahn JR, Shumway NP. Preparation and function of the hypertension-converting enzyme. J Exp Med. 1956; 103: 295-299.
43. Jaspard E, Costerouse O, Wei L, Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase). J Biol Chem. 1993; 268: 9496-9503.
44. 4OH treatment. Arch Biochem Biophys. 1983; 227: 188-201.
45. Hooper NM. Angiotensin converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem. 1991; 23: 641-647.
46. Santos RAS, Krieger ME, Greene LJ. In a improved fluorometric assay rat serum and plasma converting enzyme. Hypertension. 1985; 7: 244-252.
47. Kokubo T, Kato I, Nishimura K, Hiwada K, Ueda E. Angiotensin converting enzyme in urine. Clin Chem Acta. 1978; 89: 375-379.
48. Nishmura K, Yoshida N, Hiwada K, Ueda E, Kokubo T. Properties of three different forms of angiotensin I-converting enzyme from human lung. Biochem Biophys Acta. 1978; 522: 229-237.
49. Santos RAS, Campagnole-Santos MJ. Central and peripheral actions of angiotensin 1-7. Braz J Med Biol Res. 1994; 27: 1033-1047.
50. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 1998; 31: 362-367.
51. Deddish PA, Maic B, Jackman HL, Wang HZ, Skidgel RAS. N-Domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme. Angiotensin-(1-7) and keto-ACE. Hypertension. 1998; 31: 912-917.
52. Yang HYT, Erdös EG, Levin Y. A dipeptidyl carboxy-peptidase that converts angiotensin-I and inactivates bradykinin. Biochem Biophys Acta. 1970; 214: 374-376.
53. Rousseau A, Michaud A, Chauvet MT, Lenfant M, Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem. 1995; 270: 3656-3661.
54. Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Mènard J. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 1996; 97: 839-844.
55. Williams TA, Danilov S, Alhenc-Gelas F, Soubrier F. A study of chimeras with the two domains of angiotensin I-converting enzyme. Biochem Pharmacol. 1996; 51: 11-14.
56. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin converting-enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 1988; 85: 9386-9390.
57. Cambien F, Poirier O, Lecerf L, Evas A, Cambou JP, Arveiller D, Gerard L, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359: 641-644.
58. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992; 51: 197-210.
59. Schunkert H, Hense HW, Muscholl M, Luchner A, Riegger GA. Association of angiotensin converting enzyme activity and arterial blood pressure in a population-based sample. J Hypertens. 1996; 14: 571-575.